United Therapeutics UTHR
NASDAQ UTHR
$549.98 -21.40 (-3.74%)
As of: Oct 2, 2026 · 11:04 AM EDT

United Therapeutics (UTHR) Non Operating Interest Expenses (2009 - 2026)

Updated

United Therapeutics (UTHR) recorded Non Operating Interest Expenses of $2.9 million in Q2 2026, down 60.3% from $7.3 million a year earlier and down 3.3% from the prior quarter.

Analysis

United Therapeutics (UTHR) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a TTM basis, United Therapeutics' Non Operating Interest Expenses came in at $12 million as of Jun 30, 2026, down 61.8% year-over-year; for FY2025, it came in at $19.5 million, down 54.5% from FY2024.

  • Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
  • Across earlier years, Non Operating Interest Expenses came in at $42.9 million in FY2024 (-27.7%), $59.3 million in FY2023 (+83.0%), $32.4 million in FY2022 (+74.2%) and $18.6 million in FY2021 (-20.9%).
  • On a year-over-year basis, Non Operating Interest Expenses has declined for ten consecutive quarters, with an average decline of 52.0% over the last eight quarters.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 193.6% in Q1 2023, against a decline of 70.3% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3 million (Q1 2026), $3.1 million (Q4 2025) and $3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 United Therapeutics 23.13 Bn 12.62 Bn 683.80 Mn 2.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.90 Mn
Mar 31, 2026 3.00 Mn
Dec 31, 2025 3.10 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 7.30 Mn
Mar 31, 2025 6.10 Mn
Dec 31, 2024 7.90 Mn
Sep 30, 2024 10.10 Mn
Jun 30, 2024 11.60 Mn
Mar 31, 2024 13.30 Mn
Dec 31, 2023 15.10 Mn
Sep 30, 2023 15.60 Mn
Jun 30, 2023 14.80 Mn
Mar 31, 2023 13.80 Mn
Dec 31, 2022 12.30 Mn
Sep 30, 2022 9.20 Mn
Jun 30, 2022 6.20 Mn
Mar 31, 2022 4.70 Mn
Dec 31, 2021 4.70 Mn
Sep 30, 2021 4.60 Mn
API Access

United Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=UTHR&period=max&api_key=YOUR_API_KEY